Healthcare entity

CRISIL Intelligence

Company

Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Authentication Solution Providers' Association, the most common co-covered peer. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window.

Last mentioned: Mar 17, 2026

Entity pulse

Recent coverage · CRISIL Intelligence

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about CRISIL Intelligence

Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Authentication Solution Providers' Association, the most common co-covered peer. Each story carries 2 original sources on average, compared with 3.1 for the broader beat in this window. The 7 average consequence score is above the beat benchmark of 6.3 in the same window. We currently track 1 Healthcare story that mention CRISIL Intelligence, all published on March 17, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering CRISIL Intelligence. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning CRISIL Intelligence 1

Market Trends Negative

India’s Counterfeit Crisis: 28% of Pharma Market Impacted as Online Sales Surge

A new report by ASPA and CRISIL reveals that 35% of Indian consumers encountered counterfeit goods in the past year, with online platforms driving 53% of these transactions. The pharmaceutical sector is particularly hard-hit, with fake medicines estimated to comprise 28% of the market, posing significant public health risks.

2 sources

Source: Abhinav Singh (in) · Anilast Updated (in)

CRISIL Intelligence is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.